Eniayo Egberongbe
Psychiatric/Mental Health · Cranston, RINPI 1295263515
Payments from drug & device makers
Across 608 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$1K
- Lundbeck LLC$693
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $2,442 |
| Teva Pharmaceuticals USA, Inc. | 81 | $1,476 |
| Otsuka America Pharmaceutical, Inc. | 74 | $1,309 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 50 | $1,050 |
| Alkermes, Inc. | 52 | $1,012 |
| Lundbeck LLC | 42 | $693 |
| Vanda Pharmaceuticals Inc. | 25 | $650 |
| Neurocrine Biosciences, Inc. | 28 | $608 |
| Corium, LLC | 29 | $508 |
| Axsome Therapeutics, Inc. | 20 | $466 |
| Johnson & Johnson | 11 | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $381 |
| E.r. Squibb & Sons, L.L.C. | 23 | $299 |
| Supernus Pharmaceuticals, Inc. | 13 | $254 |
| Ironshore Pharmaceuticals Inc. | 12 | $193 |
| Sage Therapeutics, LLC | 5 | $101 |
| Sunovion Pharmaceuticals Inc. | 5 | $97 |
| Idorsia Pharmaceuticals US Inc | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $42 |
| AstraZeneca | 2 | $33 |
| Boehringer Ingelheim | 1 | $26 |
| Abbott | 1 | $22 |
| Bayer | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Medtronic | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Amgen | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
How this compares
$12,291 in reported general payments places this provider in the 95th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatric/mental health in Cranston
- Anita ObengCranston$8K
- Cristiana RitwikCranston$4K
- Barbara ForloneyCranston$3K
- Taramarie PiecykCranston$3K
- Tanille LouisCranston$2K
- Samantha Shawn MarshBradford$639K
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Deborah HorvitzWarwick$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.